Asthma treatment with combination inhaler
Part of Immune system & allergy, Lungs & breathing clinical trials.
This study tests a new combination inhaler for people with asthma. It may help control symptoms and improve breathing. Participants will either get the study inhaler or a standard treatment, and their asthma will be monitored closely.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old.
- You have been diagnosed with asthma for at least 3 months.
- Your asthma is not well controlled with your current inhaler, or it is well controlled if you use a combination inhaler.
- You are willing to switch to the study's rescue inhaler for symptom relief.
- You have not smoked for at least 6 months (and your lifetime smoking history is less than 10 pack-years).
- You do not have other significant lung diseases (like COPD or bronchiectasis).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests two ways to use common asthma inhalers (budesonide and formoterol) to see if a simple, everyday approach can control mild asthma symptoms better and with less need for rescue medicine.
This study compares a three-in-one inhaler (ICS/LABA/LAMA) to a two-in-one inhaler (ICS/LABA) for adults whose asthma is not well-controlled despite using a standard two-in-one inhaler. The goal is to see if the triple inhaler improves asthma control better.
This trial uses special imaging to look at how air moves through your lungs. It may help doctors understand asthma better and could lead to better treatments.
This trial tests whether a new combination inhaler works as well as a commonly used one for teenagers with asthma that is not well controlled. It aims to find a safe and effective treatment option for adolescents.
This study tests whether adding an immune-modulating tablet (made from bacteria) to a standard combination inhaler for asthma improves asthma control more than the inhaler alone. The study aims to see if this combination helps reduce symptoms and lung inflammation.
This study checks whether a new albuterol inhaler works the same way as a reference inhaler in adults with stable, mild asthma. It may help you (and others) by confirming that the inhaler delivers the right effect and is safe to use.
Hear when a new Asthma (Diagnosis) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.